DRTS News and Press, Alpha Tau Medical Ltd. From 06/17/22

Do You Have These 4 Biotech Stocks on Your Watchlist? Biotech stocks have been one of the focal points of the stock market over the past two years. For obvious reasons, people and investors alike are always on the lookout for new developments against the coronavirus. But even wi...

Alpha Tau Announces Receipt of Radioactive License to Allow Production in Main Manufacturing Floor at its Jerusalem Site, Amended Radioactive License with Increased Capacity at Lawrence, MA Site PR Newswire JERUSALEM , June 16, 2022 /PRNewswire/ -- Alpha ...

Gainers: Cogent Biosciences (COGT) +89%. Redbox Entertainment (RDBX) +48%. Alpha Tau Medical (DRTS) +23%. Bright Green Corporation (BGXX) +17%. Aridis Pharmaceuticals (ARDS) +18%. Wah Fu Education Group (WAFU) +14%. Powerbridge Technologies (PBTS) +12%. Hycroft Mining Holding Corporation (HYM...

Medical device maker Alpha Tau (NASDAQ:DRTS +11.9%) said on Wednesday the U.S. Food and Drug Administration conditionally approved its investigational device exemption application to begin multi-center study to treat recurrent cutaneous Squamous Cell Carcinoma (SCC) using its alpha-...

Alpha Tau Announces FDA Approval of IDE to Initiate Multi-Center Pivotal Study of Alpha DaRT™ in Recurrent Cutaneous SCC PR Newswire JERUSALEM , June 8, 2022 /PRNewswire/ -- Alpha Tau Medical Ltd. (Nasdaq: DRTS and DRTSW), ("Alpha Tau" or the "Comp...

Alpha Tau Announces Resignation of Gary Leibler from its Board of Directors PR Newswire JERUSALEM , June 7, 2022 /PRNewswire/ -- Alpha Tau Medical Ltd. (Nasdaq: DRTS) (Nasdaq: DRTSW), ("Alpha Tau" or the "Company"), the developer of the innovative alpha-r...

Gainers: Avadel Pharmaceuticals AVDL +61%. PMV Pharmaceuticals PMVP +25%. Alpha Tau Medical (DRTS) +18%. SIGA Technologies SIGA +18%. Allarity Therapeutics (ALLR) +17%. Losers: Iovance Biotherapeutics (IOVA) -54%. SpringWorks Therapeutics SWTX...

Alpha Tau Medical press release (NASDAQ:DRTS): Q1 GAAP EPS of -$0.54. Cash and cash equivalents of $98.07M For further details see: Alpha Tau Medical GAAP EPS of -$0.54

Alpha Tau Medical Announces First Quarter 2022 Financial Results and Provides Corporate Update PR Newswire -Debuted as publicly-traded oncology company in March 2022 under symbol DRTS while raising approximately $104 million in gross proceeds- -Targeted...

First Alpha DaRT Patients Treated in France as Part of Alpha DaRT™ Multicenter Skin Cancer Trial PR Newswire JERUSALEM , May 23, 2022 /PRNewswire/ -- Alpha Tau Medical (Nasdaq: DRTS) (Nasdaq: DRTSW) , the developer of the pioneering alpha-r...